"Dr. Ajai Chari Outlines Disparities and Treatment Patterns in Multiple Myeloma"
Ajai Chari, MD, associate professor, hematology and medical oncology at the Icahn School of Medicine at Mount Sinai, discusses multiple myeloma. “Research has shown disparities in multiple myeloma treatment between clinical trials and real-world outcomes, as well as a lot of heterogeneity among treatment patterns by age and region.” He added, “The disparities relate to the differences between clinical trials and real-world outcomes. So, in clinical trials we cherry picked really healthy patients.”
— Ajai Chari, MD, Director, Clinical Research in the Multiple Myeloma Program, Associate Director, Clinical Research, Mount Sinai Cancer Clinical Trials Office, Associate Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai
Mount Sinai Scientists Create AI-Powered Tool to Improve Cancer Tissue Analysis
Aug 25, 2025 View All Press Releases
Combination Therapy Improves Outcomes for Advanced Triple-Negative Breast Cancer
Aug 21, 2025 View All Press Releases
Mount Sinai Researchers Engineer Rare Immune Cells to Create Powerful New Cancer Vaccine
Jul 21, 2025 View All Press Releases
Mount Sinai Study Advances Understanding of Personalized Vaccines for Bladder Cancer
May 12, 2025 View All Press Releases
Mount Sinai Researchers Discover How Melanoma May Spread to the Brain
Apr 30, 2025 View All Press Releases
Mount Sinai Showcases Innovative Cancer Research at 2025 AACR Annual Meeting in Chicago
Apr 24, 2025 View All Press Releases